The global Dental bone graft substitute market size is projected to reach USD 659 million by 2025 from USD 450 million in 2020, at a CAGR of 7.9% during the forecast period. Factors such as the technological advancements in the market are propelling the growth of the dental bone graft substitutes market. Moreover, increasing demand from customers, rising inclination towards cosmetic dentistry and growing industry standards are spurring the growth of the global dental bone grafts substitutes market. However, unfavorable reimbursement scenarios in some countries is hampering the growth of this market.
Dentsply Sirona (US), Johnson & Johnson (US), Danaher Corporation (US), Medtronic (Ireland), Strauman (US), Zimmer Dental (US), Geistlich Pharm (Switzerland), RTI Surgical (US), BioHorizons, IPH, Inc (US), Dentium (South Korea), LifeSciences Corporation (US), Smith & Nephew (UK), Novabone LLC (US), Botiss biomaterials GmbH (US), Collagen Matrix Inc. (US), Osteogenics Biomedical (US), LifeNet Health (US), Wright Medical (US), and Stryker Corporation (US) are some of the major players in the dental bone graft substitue market among others. The analysis of market developments between 2014 and 2019 revealed that several growth strategies such as research collaborations and strategic market expansions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the dental bone graft substitute market.
To know about the assumptions considered for the study download the pdf brochure
Dentsply Sirona Inc. is a leading provider of dental products. The company adopted acquisitions, new product launches, and agreements as its key growth strategies. Dentsply Sirona, the world’s largest and most diversified manufacturer of professional dental products and technologies, has established a new Lab Strategic Business Unit (SBU) incorporating the successful Laboratory CAD/CAM business with the renowned Dentsply Sirona Prosthetics material business. In accordance with this strategy, in February 2016, the company merged with DENTSPLY International Inc. This helped the company to expand its business and product offerings in the dental bone graft substitutes market.
Danaher is one of the leaders in designing, manufacturing, and marketing innovative products and services to professional, medical, industrial, and commercial customers. The company holds a significant share in the global dental bone graft substitute market. To maintain its market position and ensure future growth, the company adopts organic and inorganic growth strategies. In line with this, Danaher also focuses on R&D to provide its customers with innovative products and to maintain a competitive position in the market. The company’s efforts to strengthen its product portfolio, expand its geographic reach, and increase its brand visibility are expected to drive its growth in the dental bone graft substitute market.
Dental Bone Graft Substitute Market by Type (Synthetic Bone Grafts, Xenograft, Allograft, Alloplast), Application (Sinus Lift, Ridge Augmentation, Socket Preservation), Product (Bio-OSS, OsteoGraf, Grafton), End User (Hospital)- Global Forecast to 2025
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.SEND ME A FREE SAMPLE